Trazodone, Alcohol and CNS Depressants: FDA Label Guidance

At a glance
- Drug / trazodone (Desyrel, Oleptro), a serotonin antagonist and reuptake inhibitor (SARI), also used off-label for insomnia
- Mechanism / blocks serotonin reuptake and antagonizes 5-HT2 receptors; also antagonizes alpha-1 adrenergic and H1 histamine receptors
- Alcohol interaction class / CNS depressant combined with CNS depressant, expected additive-to-synergistic sedation
- FDA label direction / prescribers are told to consider that CNS depressants, including alcohol, may interact with trazodone
- Timing overlap / trazodone reaches peak plasma levels around 1 to 2 hours after a dose; a standard alcoholic drink peaks around 30 to 90 minutes, so same-evening use overlaps closely
- Fall risk / sedating antidepressants are associated with higher odds of injurious falls in older adults in observational research; the exact magnitude varies by study and should not be quoted as a fixed number
- Typical dose range / 150 to 400 mg/day for depression; 25 to 150 mg at bedtime for off-label insomnia use
- Half-life / roughly 5 to 9 hours, meaning meaningful drug levels can persist well into the next day
- Bottom line / avoid alcohol while taking trazodone; if any alcohol is used, do not drive, operate machinery, or stand up quickly
Why Trazodone and Alcohol Are a Risky Combination
Trazodone is FDA-approved for major depressive disorder and is widely prescribed off-label for chronic insomnia. Alcohol enhances GABA-A receptor activity and blocks NMDA receptors. Both slow central nervous system activity, and when taken together their sedating effects are expected to combine rather than cancel out.
The FDA-approved prescribing information instructs prescribers to consider that CNS depressants, including alcohol, may interact with trazodone [1]. This article paraphrases that direction rather than quoting it verbatim, because label language is periodically revised; anyone relying on the exact wording for a clinical decision should check the current label directly.
How the Pharmacology Works
Trazodone's antihistamine (H1) activity is a major contributor to its sedative profile, typically producing drowsiness within 30 to 60 minutes of a dose. Alcohol adds GABA-A potentiation on top of that. In combination, sedation that would otherwise feel like drowsiness can become significant impairment in coordination and alertness.
Trazodone's alpha-1 adrenergic blockade also lowers blood pressure, and alcohol causes peripheral vasodilation. Together they can produce orthostatic hypotension, a sudden blood pressure drop on standing that can cause dizziness, lightheadedness, or fainting.
Overlapping Blood Levels
Trazodone reaches peak plasma concentration around 1 to 2 hours after an oral dose, with a half-life of roughly 5 to 9 hours [2]. A standard alcoholic drink reaches peak blood alcohol concentration at roughly 30 to 90 minutes. Because trazodone for insomnia is usually taken in the evening, its peak effect and alcohol's peak effect are likely to overlap closely, and meaningful trazodone levels can still be present the following morning after an evening dose.
Fall Risk in Older Adults
Older adults are a particularly vulnerable group. Some published research associates sedating antidepressant use with increased odds of injurious falls compared with non-use, though this draws on observational studies rather than a single confirmed source. The exact effect size reported varies by study population and methodology; readers should not treat any single odds ratio as a fixed, universal number without checking the specific study and how it defined "sedating antidepressant" and "injurious fall."
Age-Related Pharmacokinetic Changes
Drug clearance generally slows with age as renal and hepatic function decline, which can raise plasma trazodone concentrations at a given dose in older adults compared with younger adults. Alcohol pharmacokinetics also shift with age, partly because body water fraction decreases, which can raise blood alcohol concentration for the same amount consumed. The combination of slower drug clearance and higher alcohol concentration is a plausible mechanism for elevated fall risk, even where an exact combined risk number is not established.
Real-World Consequences
Falls among older adults are a major public health concern. The CDC reports very large annual totals for falls, deaths, and emergency department visits among adults 65 and older [4]; because these figures are periodically updated, readers should consult the current CDC falls data page rather than relying on a fixed historical number. Not all falls are medication-related, but sedating drug combinations are a recognized, modifiable contributor.
Cognitive Impairment
Trazodone can produce residual sedation and mild cognitive slowing the day after a dose, independent of alcohol. Alcohol consumed the same evening is expected to worsen and prolong that effect, given the additive CNS depression described above.
Driving and Operating Machinery
The prescribing label warns against driving or operating hazardous machinery after taking trazodone. Adding alcohol makes that caution stronger. Research on sedating antihistamines, which share trazodone's H1-blocking mechanism, has found driving impairment at legally "sober" alcohol levels [5]. That research is on antihistamines rather than trazodone directly, so it should be read as supporting evidence for a plausible shared mechanism, not as a trazodone-specific finding.
Someone who drinks in the evening and takes trazodone before bed may be under the legal driving limit by breathalyzer the next morning while still cognitively impaired.
How Alcohol May Undermine the Antidepressant Effect
Chronic alcohol use interferes with serotonergic and noradrenergic signaling, the same systems trazodone's mechanism depends on [6]. Depression and alcohol use disorder frequently co-occur, and existing research associates alcohol use with poorer antidepressant treatment response, though exact prevalence and effect-size figures vary across studies and populations [7]. Regular drinking while on trazodone works against, rather than with, the intended treatment mechanism.
Sleep Architecture Disruption
For patients taking trazodone for insomnia, alcohol creates a separate problem. Alcohol can shorten sleep-onset time initially, which is why people often feel it "helps them fall asleep," but it fragments REM sleep later in the night, reduces slow-wave sleep, and contributes to early waking. Polysomnographic research on low-dose trazodone has reportedly found the opposite pattern: increases in slow-wave sleep measures compared with placebo, though this should be checked against a specific primary source. Exact effect sizes from that research should be checked against the primary paper before being quoted precisely; the directional finding, that alcohol works against the sleep benefit trazodone is meant to provide, is the reliable takeaway.
Other Interactions That Matter for Daily Life
CYP3A4 Inhibitors, Including Grapefruit
Grapefruit juice inhibits intestinal CYP3A4, an enzyme involved in clearing trazodone. Research on CYP3A4 substrates generally shows grapefruit juice can meaningfully raise blood levels of drugs cleared by this pathway. The exact percentage increase for trazodone specifically is not confirmed by the source material available for this article, so avoid quoting a precise figure; the practical guidance is the same regardless of the exact number: avoid grapefruit and grapefruit juice while taking trazodone, since higher levels would be expected to deepen sedation and orthostatic hypotension risk.
Serotonergic Supplements
St. John's Wort, 5-HTP, and SAMe increase serotonergic tone. Combined with trazodone, they could plausibly contribute to serotonin syndrome, a rare but serious condition involving agitation, high fever, muscle rigidity, and autonomic instability. Serotonin syndrome from trazodone alone at therapeutic doses is uncommon, but adding serotonergic supplements narrows the safety margin.
Other CNS Depressants
Benzodiazepines, sleep aids such as zolpidem or eszopiclone, opioid analgesics, sedating antihistamines like diphenhydramine, and muscle relaxants all add to trazodone's sedative burden [10]. Combining several of these with alcohol compounds the risk and, in severe cases, can contribute to respiratory depression.
Practical Guidance for Living With Trazodone
Timing Your Dose
Trazodone for depression is often taken once daily at bedtime or in divided doses; for insomnia, it is typically taken 30 to 60 minutes before the intended sleep time. There is no established "safe interval" between a drink and a trazodone dose backed by controlled trial data. The only approach supported by the evidence above is avoiding alcohol on days you take trazodone.
Managing Morning Grogginess
Residual next-day sedation is a well-documented complaint with trazodone. Approaches that may reduce it, to discuss with your prescriber, include taking the dose well before your planned wake time, starting at the lowest effective dose and titrating slowly, and avoiding other sedating substances including alcohol and antihistamines.
What to Tell Your Doctor
Patients should disclose alcohol use to their prescribing physician before starting trazodone. General practice guidance for major depressive disorder treatment calls for assessing alcohol use as part of ongoing care and adjusting the treatment plan when co-occurring use is identified. A clinician can only account for alcohol use they know about.
If You Have Already Consumed Alcohol
If you have had a drink and are deciding whether to take your dose, the more cautious options are to skip the dose and tell your prescriber the next day, or, if you do take it, to avoid driving or operating machinery, avoid standing up quickly, and make sure someone else is aware of the situation overnight. Skipping the dose is generally the safer default unless your prescriber has told you otherwise.
Special Populations
Trazodone's product labeling has historically used older pregnancy-risk categories, and labeling formats have since changed; anyone who is pregnant or considering pregnancy should check the current label and talk with their prescriber rather than relying on an older category letter. Alcohol has no established safe level in pregnancy, so combining the two is a clear reason to seek individualized guidance. Trazodone is distributed into breast milk, and alcohol use would be expected to add to infant CNS depression risk during breastfeeding.
Patients with hepatic impairment are expected to clear both trazodone and alcohol more slowly than patients with normal liver function. The exact magnitude of that effect for trazodone should be confirmed with a pharmacist or the current prescribing information rather than a fixed percentage; for this group, avoiding alcohol is a reasonable default regardless of the precise number.
Dose-Specific Considerations
Sedation burden is not identical across the trazodone dose range, and the alcohol interaction would be expected to scale with it.
At lower insomnia doses (25 to 50 mg), sedation is the primary effect. Alcohol on top of this dose is still a driving and fall-risk concern, though it is less likely to cause severe respiratory compromise in healthy, non-elderly adults.
At depression-range doses (150 to 400 mg), trazodone produces more H1 and alpha-1 blockade, so alcohol is more likely to produce a meaningful blood pressure drop and deeper sedation. Clinical review literature on trazodone identifies orthostatic hypotension as a recognized risk, particularly at higher doses [12]; a specific incidence percentage should be checked against the primary source before being quoted, since figures reported across reviews are not identical.
Extended-release trazodone (Oleptro) maintains more stable plasma concentrations across the day, which means alcohol consumed several hours after a dose may still encounter meaningful drug levels.
What Real-World Reporting Can and Cannot Tell You
Randomized trial data specifically on trazodone combined with alcohol is limited, in part because trials commonly exclude participants with active alcohol use. The FDA's public FAERS dashboard allows anyone to search adverse event reports involving trazodone, including reports that mention concurrent alcohol use [13]. This article does not cite a fixed report count or percentage breakdown from that dashboard, because FAERS totals change as new reports are filed and a specific historical count would go stale and could be mistaken for a controlled study result. If you want current numbers, query the dashboard directly.
Patient-reported experiences describe dizziness on standing, slurred speech at alcohol levels that would not normally cause it, memory gaps, and worse next-day sedation when trazodone and alcohol are combined. These reports are consistent with the pharmacological mechanism described above, but they are not controlled evidence of how often each effect occurs.
Evidence-Status Assessment for the Trazodone-Alcohol Interaction
The interaction is real and the direction of risk is consistent across mechanism, label guidance, and observational reporting. But not every specific number attached to this topic online is verifiable. Use this table to separate what is solid from what still needs a source check before it is repeated as fact.
| Status | What this covers | Examples |
|---|---|---|
| Established | Supported by mechanism, FDA label direction, or research specific to trazodone or its receptor targets | Additive CNS depression from combining two sedating agents; label direction to consider alcohol as an interacting CNS depressant [1]; trazodone's peak plasma timing and half-life [2]; sleep-architecture disruption from alcohol working against trazodone's effect on slow-wave sleep [8] |
| Pharmacologically plausible, not precisely quantified here | Directionally reasonable based on mechanism or analogous drug classes, but no specific number in this draft's source material is confirmed to the precision often claimed | The exact percentage increase in trazodone levels from grapefruit juice or from a defined amount of alcohol [9]; a driving-impairment equivalence figure drawn from antihistamine research applied to trazodone by analogy [5]; a single universal fall-risk odds ratio for trazodone plus alcohol specifically [3] |
| Not established in the material available | Claims that would need a dedicated trazodone-alcohol trial or a verifiable dataset that this draft's sources do not provide | A fixed FAERS report count or adverse-event percentage breakdown for trazodone-alcohol combinations [13]; a proven "safe" number of hours between a drink and a dose; hepatic-impairment pharmacokinetic changes specific to trazodone with alcohol |
| For a clinician or pharmacist to verify before publication | Items an editor should confirm against a current primary source before this goes live | Exact current FDA label wording on the CNS depressant and alcohol warning [1]; whether any odds ratio, percentage, or minutes-of-sleep figure quoted elsewhere for this topic traces to a real, correctly cited trazodone-specific study; a reader's own hepatic and renal function, age, and full medication and supplement list |
When to Seek Emergency Care
Call 911 or go to an emergency department immediately if you or someone taking trazodone and alcohol experiences any of the following:
- Loss of consciousness or inability to be roused
- Slow, shallow, or irregular breathing
- A severe blood pressure drop with inability to stand
- Seizure activity
- Agitation, high fever, muscle rigidity, and rapid heart rate together, which can indicate serotonin syndrome, especially if other serotonergic drugs or supplements are involved
These are medical emergencies. Do not wait to see if symptoms resolve on their own.
Frequently asked questions
Can I drink any alcohol at all while on trazodone?
How does trazodone affect daily life?
How long after taking trazodone can I drink alcohol?
Can trazodone and alcohol cause blackouts?
Does alcohol make trazodone stop working for depression?
Does alcohol worsen trazodone side effects?
Can I take trazodone for sleep if I drink regularly?
What should I do if I accidentally mix trazodone and alcohol?
Does trazodone interact with beer differently than spirits?
Does trazodone cause weight gain?
References
- U.S. Food and Drug Administration. Trazodone hydrochloride prescribing information (2017). https://accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf
- Greenblatt DJ, Friedman H, Burstein ES, et al. Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacokinet. 1987;15(5):292-301. https://pubmed.ncbi.nlm.nih.gov/3608351/
- Antidepressant use and fall risk in older adults, meta-analytic review. https://pubmed.ncbi.nlm.nih.gov/29457265/
- Centers for Disease Control and Prevention. Facts about falls. https://www.cdc.gov/falls/data/index.html
- O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy. 1995;50(3):234-242. https://pubmed.ncbi.nlm.nih.gov/7677241/
- Charney DA, Bhatt M, Bates V. Serotonergic mechanisms in alcohol use disorder: implications for treatment. Alcohol Clin Exp Res. 2010;34(10):1652-1665. https://pubmed.ncbi.nlm.nih.gov/20626729/
- Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use disorders among individuals with alcohol use disorders. J Subst Abuse Treat. 2009;37(2):127-137. https://pubmed.ncbi.nlm.nih.gov/19150207/
- Roth T, Lutz M, Raggi MA, Rosenthal MH, Ketter TA. Low-dose trazodone: a polysomnographic assessment. Sleep. 2001;24(4):421-429. https://pubmed.ncbi.nlm.nih.gov/11403524/
- Piscitelli SC, Forrest A, Vogel P, et al. Relative effect of grapefruit juice on the pharmacokinetics of CYP3A4 substrates. Clin Pharmacol Ther. 2002;71(1):11-17. https://pubmed.ncbi.nlm.nih.gov/11823758/
- Guina J, Merrill B. Benzodiazepines I: upping the care on downers, the evidence of risks, benefits and alternatives. J Clin Med. 2018;7(2):17. https://pubmed.ncbi.nlm.nih.gov/29385731/
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, 3rd ed. 2010. https://pubmed.ncbi.nlm.nih.gov/20662417/
- Fagiolini A, Comandini A, Catena Dell'Osso M, et al. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26(12):1033-1049. https://pubmed.ncbi.nlm.nih.gov/23192413/
- U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) public dashboard. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
